Literature DB >> 25241023

The effect of tomato juice supplementation on biomarkers and gene expression related to lipid metabolism in rats with induced hepatic steatosis.

Gala Martín-Pozuelo1, Inmaculada Navarro-González, Rocío González-Barrio, Marina Santaella, Javier García-Alonso, Nieves Hidalgo, Carlos Gómez-Gallego, Gaspar Ros, María Jesús Periago.   

Abstract

PURPOSE: Tomato products are a dietary source of natural antioxidants, especially lycopene, which accumulates in the liver, where it exerts biological effects. Taking into consideration this fact, the aim of the present study was to ascertain the effect of tomato consumption on biomarkers and gene expression related to lipid metabolism in rats with induced steatosis.
METHODS: Adult male Sprague-Dawley rats (8 weeks old) were randomly grouped (n = 6 rats/group) in four experimental groups: NA (normal diet and water), NL (normal diet and tomato juice), HA (high fat diet and water) and HL (high fat diet and tomato juice). After 7 weeks, rats were euthanized, and plasma, urine, feces and liver were sampled to analyze the biomarkers related to lipid metabolism, inflammation and oxidative stress.
RESULTS: The H diet induced steatosis (grade II) in the HA and HL groups, which was confirmed by the levels of alanine aminotransferase and aspartate aminotransferase, histological examination and the presence of dyslipidemia. The intake of tomato juice led to an accumulation of all-E and Z-lycopene and its metabolites in the livers of these animals; levels were higher in HL than in NL, apparently due to higher absorption (63.07 vs. 44.45%). A significant improvement in the plasma level of high-density lipoprotein was observed in the HL group compared with HA animals, as was an alleviation of oxidative stress through reduction of isoprostanes in the urine. In relation to fatty acid gene expression, an overexpression of several genes related to fatty acid transport, lipid hydrolysis and mitochondrial and peroxisomal β-fatty acid oxidation was observed in the HL group.
CONCLUSIONS: The consumption of tomato juice and tomato products reduced hallmarks of steatosis, plasmatic triglycerides and very low-density lipoproteins, and increased lipid metabolism by inducing an overexpression of genes involved in more efficient fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241023     DOI: 10.1007/s00394-014-0770-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  49 in total

1.  Proteomics and gene expression analyses of mitochondria from squalene-treated apoE-deficient mice identify short-chain specific acyl-CoA dehydrogenase changes associated with fatty liver amelioration.

Authors:  Adela Ramírez-Torres; Sílvia Barceló-Batllori; Erika Fernández-Vizarra; María A Navarro; Carmen Arnal; Natalia Guillén; Sergio Acín; Jesús Osada
Journal:  J Proteomics       Date:  2012-03-03       Impact factor: 4.044

2.  Changes in antioxidant compounds during the shelf life of commercial tomato juices in different packaging materials.

Authors:  Francisco J García-Alonso; Sergio Bravo; Javier Casas; Darío Pérez-Conesa; Karin Jacob; María J Periago
Journal:  J Agric Food Chem       Date:  2009-08-12       Impact factor: 5.279

3.  [Direct estimation of creatinine in serum and in urine without deproteinization using a modified Jaffé method].

Authors:  R Helger; H Rindfrey; J Hilgenfeldt
Journal:  Z Klin Chem Klin Biochem       Date:  1974-07

Review 4.  From the metabolic syndrome to NAFLD or vice versa?

Authors:  Ester Vanni; Elisabetta Bugianesi; Anna Kotronen; Samuele De Minicis; Hannele Yki-Järvinen; Gianluca Svegliati-Baroni
Journal:  Dig Liver Dis       Date:  2010-03-06       Impact factor: 4.088

5.  Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.

Authors:  C Wolfrum; C M Borrmann; T Borchers; F Spener
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo O Castaño; Adriana L Burgueño; María Soledad Rosselli; Tomas Fernández Gianotti; Pablo Mallardi; Julio San Martino; Carlos Jose Pirola
Journal:  Atherosclerosis       Date:  2009-10-13       Impact factor: 5.162

9.  Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis.

Authors:  Takeshi Tomonaga; Kazuyuki Matsushita; Seiko Yamaguchi; Masamichi Oh-Ishi; Yoshio Kodera; Tadakazu Maeda; Hideaki Shimada; Takenori Ochiai; Fumio Nomura
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

10.  Altered desaturation and elongation of fatty acids in hormone-sensitive lipase null mice.

Authors:  Céline Fernandez; Kai Schuhmann; Ronny Herzog; Barbara Fielding; Keith Frayn; Andrej Shevchenko; Peter James; Cecilia Holm; Kristoffer Ström
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

View more
  10 in total

Review 1.  Carotenoids and non-alcoholic fatty liver disease.

Authors:  Bahiddin Yilmaz; Kazim Sahin; Hande Bilen; Ibrahim H Bahcecioglu; Birdal Bilir; Sara Ashraf; Karim J Halazun; Omer Kucuk
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

2.  Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

Authors:  Minkyung Bae; Mi-Bo Kim; Hyunju Kang; Young-Ki Park; Ji-Young Lee
Journal:  Lipids       Date:  2019-05-29       Impact factor: 1.880

Review 3.  Impact of nutrients and food components on dyslipidemias: what is the evidence?

Authors:  Carla de Oliveira Barbosa Rosa; Carolina Araújo Dos Santos; Jacqueline Isaura Alvarez Leite; Ana Paula Silva Caldas; Josefina Bressan
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

Review 4.  The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease.

Authors:  Ana Gabriela Murillo; Diana M DiMarco; Maria Luz Fernandez
Journal:  Biology (Basel)       Date:  2016-11-08

5.  Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis.

Authors:  Gala Martín-Pozuelo; Rocío González-Barrio; Gonzalo G Barberá; Amaya Albalat; Javier García-Alonso; William Mullen; Harald Mischak; María Jesús Periago
Journal:  Int J Mol Sci       Date:  2016-10-26       Impact factor: 5.923

6.  Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.

Authors:  Ruiwen Wang; Zhecheng Wang; Ruimin Sun; Rong Fu; Yu Sun; Meiyang Zhu; Yunfei Geng; Dongyan Gao; Xiaofeng Tian; Yan Zhao; Jihong Yao
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

7.  Circulating carotenoids are associated with favorable lipid and fatty acid profiles in an older population at high cardiovascular risk.

Authors:  María Marhuenda-Muñoz; Inés Domínguez-López; Klaus Langohr; Anna Tresserra-Rimbau; Miguel Ángel Martínez González; Jordi Salas-Salvadó; Dolores Corella; María Dolores Zomeño; J Alfredo Martínez; Angel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramón Estruch; Francisco J Tinahones; José Lapetra; Ll Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín-Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Lidia Daimiel; Emilio Ros; Estefanía Toledo; María Fernández de la Puente Cervera; Rocío Barragán; Montse Fitó; Lucas Tojal-Sierra; Enrique Gómez-Gracia; Juan Manuel Zazo; Marga Morey; Antonio García-Ríos; Rosa Casas; Ana M Gómez-Pérez; José Manuel Santos-Lozano; Zenaida Vázquez-Ruiz; Alessandro Atzeni; Eva M Asensio; M Mar Gili-Riu; Vanessa Bullon; Anai Moreno-Rodriguez; Oscar Lecea; Nancy Babio; Francesca Peñas Lopez; Guadalupe Gómez Melis; Rosa M Lamuela-Raventós
Journal:  Front Nutr       Date:  2022-09-29

8.  Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice.

Authors:  Un Ju Jung; Yun-Young Cho; Myung-Sook Choi
Journal:  Nutrients       Date:  2016-05-19       Impact factor: 5.717

9.  Tomato Juice Supplementation Influences the Gene Expression Related to Steatosis in Rats.

Authors:  Laura Inés Elvira-Torales; Inmaculada Navarro-González; Rocío González-Barrio; Gala Martín-Pozuelo; Guillermo Doménech; Juan Seva; Javier García-Alonso; María Jesús Periago-Castón
Journal:  Nutrients       Date:  2018-09-02       Impact factor: 5.717

10.  Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Rossella Negri; Giovanna Trinchese; Fortunata Carbone; Maria Grazia Caprio; Giovanna Stanzione; Carmen di Scala; Teresa Micillo; Francesco Perna; Luca Tarotto; Monica Gelzo; Gina Cavaliere; Maria Immacolata Spagnuolo; Gaetano Corso; Giuseppina Mattace Raso; Giuseppe Matarese; Maria Pina Mollica; Luigi Greco; Raffaele Iorio
Journal:  J Clin Med       Date:  2020-01-04       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.